These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4273285)

  • 21. Fibrinolysis by protease of Aspergillus ochraceus.
    Nowak G
    Acta Univ Carol Med Monogr; 1972; 52():113-9. PubMed ID: 4669810
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mercuric chloride on the arterial blood pressure of dogs.
    Worowski K; Prokopowicz J
    Bull Acad Pol Sci Biol; 1969; 17(5):349-51. PubMed ID: 4313117
    [No Abstract]   [Full Text] [Related]  

  • 25. The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis.
    Wolf P; Farrell GW; Walton KW
    J Clin Pathol; 1972 Jan; 25(1):36-44. PubMed ID: 4259368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Normal values for hematological and hemostatic parameters in the rabbit. Determination of new parameters for experimental models of thrombosis and hemostasis].
    Monreal L; Anglés AM; Ruiz de Gopegui R; Espada Y; Monasterio J; Roncalés FJ; Monreal M
    Sangre (Barc); 1993 Oct; 38(5):365-9. PubMed ID: 8140497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysis of arterial clots. Using fibrinolysin in an isolation perfusion system.
    Wagner DE; Polishook RD; Baue AE; Blakemore WS
    Arch Surg; 1965 Nov; 91(5):712-5. PubMed ID: 4221212
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement].
    Sokołowska B; Piecuch W; Walter-Croneck A; Dmoszyńska A; Furmanik F
    Przegl Lek; 2002; 59(7):502-8. PubMed ID: 12516238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombosis and diabetic angiopathy].
    Dupuy E; Guillausseau PJ; Lubetzki J
    Nouv Rev Fr Hematol (1978); 1982; 24(3):173-7. PubMed ID: 6215622
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pseudofibrinolysis in the thrombelastogram, factor XIII and fibrinogen split products in the 2nd half of normal pregnancy, during labor, and puerperium (author's transl)].
    Riedel H; Barthels M; Trobisch H
    Z Geburtshilfe Perinatol; 1973 Oct; 177(5):339-49. PubMed ID: 4777491
    [No Abstract]   [Full Text] [Related]  

  • 32. Fenofibrate improves endothelial function and decreases thrombin-activatable fibrinolysis inhibitor concentration in metabolic syndrome.
    Kilicarslan A; Yavuz B; Guven GS; Atalar E; Sahiner L; Beyazit Y; Kekilli M; Ozer N; Oz G; Haznedaroglu IC; Sozen T
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):310-4. PubMed ID: 18469553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some aspects of fibrinogen biochemistry: interaction with proteolytic enzymes.
    Donati MB
    Acta Vitaminol Enzymol; 1973; 27(5):233-41. PubMed ID: 4274938
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
    Lassman HB; Wilkens HJ; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):317-26. PubMed ID: 4275231
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of heparin, plasmin, dextran and low-molecular-weight dextran on electrically induced thromboses.
    Flemma RJ; Acinapura AJ; Silver D; Anlyan WG
    Am Surg; 1966 Jan; 32(1):17-9. PubMed ID: 4221357
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of the fibrinolytic system in different species (author's transl)].
    Badimón L; Villaverde CA; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1980 Apr; 6(1):17-26. PubMed ID: 7387200
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of fibrinogen split products on platelets.
    Barnhart MI; Cress DC; Henry RL; Riddle JM
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):78-98. PubMed ID: 4869431
    [No Abstract]   [Full Text] [Related]  

  • 38. [The fibrinolytic system. Endogenous and exogenous activation in the drug treatment of thrombosis].
    Meneghini P; Giuron G; Gallo L; Lo Pinto G; Claudiani F
    Recenti Prog Med; 1982 Jun; 72(6):770-800. PubMed ID: 6216564
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fibrinolytic activity in the tissue, vascular wall and blood of patients with gastric disorder-observed in view of pathological and physiological factors (author's transl)].
    Suzuki T
    Nihon Geka Hokan; 1973 Oct; 42(4):357-76. PubMed ID: 4274107
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reptilase-induced molecular defect: treatment of thrombosis with Reptilase].
    Egberg N
    Nord Med; 1971 Apr; 85(14):434. PubMed ID: 5574441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.